Yes, Semaglutide is associated with a considerable decrease in major adverse cardiovascular events, making it appealing for individuals concerned about overall health.
Common side effects for both include: Nausea Vomiting Diarrhea Constipation Stomach pain Decreased appetite However, one study suggests that semaglutide has lower discontinuation rates
JAMA Intern Med 2022;182:513-9.ArticlePubMedPMC 40
Afifi, S., El-Sharif, A., Helal, Z., & El-Musallamy, E
Synergistic Metabolic Modulation and Energy Balance This profound multi-receptor activity makes the compound especially valuable in advanced preclinical and laboratory research strictly focused on energy balance, neuroendocrine appetite regulation, systemic insulin sensitivity, lipid metabolism, and complex body composition pathways
You may consider stopping the GLP-1 agonist medication once you reach your goal weight